Next-Generation COVID Vaccines Have Many Different Targets

Vaccine developers are monitoring the durability of the immune response of current COVID vaccines while racing against variants to provide more options for protection, no matter what happens next in the pandemic, according to a Medscape report.

Vaccine research, which used to be on the back burner, making only slow progress, has been fast-tracked in the past year, pushing the field of vaccinology forward, says Deborah Fuller, PhD, professor of microbiology and vaccine developer at the University of Washington School of Medicine in Seattle.

Read the full article.